An ankyrin repeat chaperone targets toxic oligomers during amyloidogenesis

Numerous age‐linked diseases are rooted in protein misfolding; this has motivated the development of small molecules and therapeutic antibodies that target the aggregation of disease‐linked proteins. Here we explore another approach: molecular chaperones with engineerable protein scaffolds such as the ankyrin repeat domain (ARD). We tested the ability of cpSRP43, a small, robust, ATP‐ and cofactor‐independent plant chaperone built from an ARD, to antagonize disease‐linked protein aggregation. cpSRP43 delays the aggregation of multiple proteins including the amyloid beta peptide (Aβ) associated with Alzheimer's disease and α‐synuclein associated with Parkinson's disease. Kinetic modeling and biochemical analyses show that cpSRP43 targets early oligomers during Aβ aggregation, preventing their transition to a self‐propagating nucleus on the fibril surface. Accordingly, cpSRP43 rescued neuronal cells from the toxicity of extracellular Aβ42 aggregates. The substrate‐binding domain of cpSRP43, composed primarily of the ARD, is necessary and sufficient to prevent Aβ42 aggregation and protect cells against Aβ42 toxicity. This work provides an example in which an ARD chaperone non‐native to mammalian cells harbors anti‐amyloidal activity, which may be exploited for bioengineering.

[1]  Karla P. Zepeda,et al.  Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 , 2022, Annals of Internal Medicine.

[2]  F. Lombardo,et al.  Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials , 2022, Journal of Alzheimer's disease : JAD.

[3]  B. Grimm,et al.  Chloroplast SRP43 autonomously protects chlorophyll biosynthesis proteins against heat shock , 2021, Nature Plants.

[4]  A. El-Alfy,et al.  Aducanumab , 2021, Reactions Weekly.

[5]  S. Linse,et al.  Charge Regulation during Amyloid Formation of α-Synuclein , 2021, Journal of the American Chemical Society.

[6]  A. Caflisch,et al.  Thermostable designed ankyrin repeat proteins (DARPins) as building blocks for innovative drugs , 2021, bioRxiv.

[7]  M. Nielsen,et al.  Improved prediction of HLA antigen presentation hotspots: Applications for immunogenicity risk assessment of therapeutic proteins , 2020, Immunology.

[8]  C. Dobson,et al.  Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies , 2020, Nature Structural & Molecular Biology.

[9]  Morten Nielsen,et al.  NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data , 2020, Nucleic Acids Res..

[10]  K. Staras,et al.  Misfolded amyloid-β-42 impairs the endosomal–lysosomal pathway , 2020, Cellular and Molecular Life Sciences.

[11]  J. Shorter,et al.  Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is inactivated by 3-methylglutaconic aciduria-linked mutations , 2020, bioRxiv.

[12]  A. Plückthun,et al.  Chaperone-assisted structure elucidation with DARPins. , 2020, Current opinion in structural biology.

[13]  Ben A Meinen,et al.  SERF engages in a fuzzy complex that accelerates primary nucleation of amyloid proteins , 2019, Proceedings of the National Academy of Sciences.

[14]  B. Kuppermann,et al.  Abicipar pegol: the non-monoclonal antibody anti-VEGF , 2019, Eye.

[15]  Y. Sugimoto,et al.  Dynamic Properties of Human α-Synuclein Related to Propensity to Amyloid Fibril Formation. , 2019, Journal of molecular biology.

[16]  C. Dobson,et al.  Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates , 2019, Science Advances.

[17]  B. Bukau,et al.  Modulation of Amyloid States by Molecular Chaperones. , 2019, Cold Spring Harbor perspectives in biology.

[18]  S. Shan,et al.  Substrate relay in an Hsp70‐cochaperone cascade safeguards tail‐anchored membrane protein targeting , 2018, The EMBO journal.

[19]  Sandeep Kumar Dhanda,et al.  Predicting HLA CD4 Immunogenicity in Human Populations , 2018, Front. Immunol..

[20]  Maya A. Wright,et al.  Cooperative Assembly of Hsp70 Subdomain Clusters , 2018, Biochemistry.

[21]  B. Grimm,et al.  Chloroplast SRP43 acts as a chaperone for glutamyl-tRNA reductase, the rate-limiting enzyme in tetrapyrrole biosynthesis , 2018, Proceedings of the National Academy of Sciences.

[22]  Sandeep Kumar Dhanda,et al.  Development of a strategy and computational application to select candidate protein analogues with reduced HLA binding and immunogenicity , 2018, Immunology.

[23]  Karsten Melcher,et al.  Amyloid beta: structure, biology and structure-based therapeutic development , 2017, Acta Pharmacologica Sinica.

[24]  S. Khare,et al.  A pH-dependent switch promotes β-synuclein fibril formation via glutamate residues , 2017, The Journal of Biological Chemistry.

[25]  E. Wanker,et al.  Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity * , 2016, The Journal of Biological Chemistry.

[26]  Michele Vendruscolo,et al.  Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation , 2016, Nature Communications.

[27]  P. Wright,et al.  Conformational dynamics of a membrane protein chaperone enables spatially regulated substrate capture and release , 2016, Proceedings of the National Academy of Sciences.

[28]  Michele Vendruscolo,et al.  Molecular mechanisms of protein aggregation from global fitting of kinetic models , 2016, Nature Protocols.

[29]  Sara Linse,et al.  Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides , 2014, Proceedings of the National Academy of Sciences.

[30]  Michele Vendruscolo,et al.  Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation , 2014, Proceedings of the National Academy of Sciences.

[31]  C. Geula,et al.  A Lifespan Observation of a Novel Mouse Model: In Vivo Evidence Supports Aβ Oligomer Hypothesis , 2014, PloS one.

[32]  Laiq-Jan Saidi,et al.  Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies , 2013, Acta neuropathologica communications.

[33]  P. Goloubinoff,et al.  Molecular chaperones as enzymes that catalytically unfold misfolded polypeptides , 2013, FEBS letters.

[34]  Yujin E. Kim,et al.  Molecular chaperone functions in protein folding and proteostasis. , 2013, Annual review of biochemistry.

[35]  Michele Vendruscolo,et al.  Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism , 2013, Proceedings of the National Academy of Sciences.

[36]  David A Bennett,et al.  Brain amyloid-β oligomers in ageing and Alzheimer's disease. , 2013, Brain : a journal of neurology.

[37]  Xiaofei Han,et al.  Soluble oligomers and fibrillar species of amyloid β-peptide differentially affect cognitive functions and hippocampal inflammatory response. , 2012, Biochemical and biophysical research communications.

[38]  Andreas Bracher,et al.  Molecular chaperones in protein folding and proteostasis , 2011, Nature.

[39]  C. Ramos,et al.  An overview of the role of molecular chaperones in protein homeostasis. , 2011, Protein and peptide letters.

[40]  Richard I. Morimoto,et al.  Chaperone networks: Tipping the balance in protein folding diseases , 2010, Neurobiology of Disease.

[41]  J. Yates,et al.  Progressive accumulation of amyloid‐β oligomers in Alzheimer’s disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins , 2010, The FEBS journal.

[42]  Chunjiang Yu,et al.  Endocytic pathways mediating oligomeric Aβ42 neurotoxicity , 2010, Molecular Neurodegeneration.

[43]  Tony Z. Jia,et al.  ATP-independent reversal of a membrane protein aggregate by a chloroplast SRP , 2010, Nature Structural &Molecular Biology.

[44]  Tim D. Jones,et al.  Prediction of Immunogenicity of Therapeutic Proteins , 2010, BioDrugs.

[45]  Sara Linse,et al.  Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. , 2010, ACS chemical neuroscience.

[46]  Tuomas P. J. Knowles,et al.  An Analytical Solution to the Kinetics of Breakable Filament Assembly , 2009, Science.

[47]  Peter M. Douglas,et al.  Molecular chaperones antagonize proteotoxicity by differentially modulating protein aggregation pathways , 2009, Prion.

[48]  Sara Linse,et al.  A facile method for expression and purification of the Alzheimer’s disease-associated amyloid β-peptide , 2009, The FEBS journal.

[49]  C. Olanow Can we achieve neuroprotection with currently available anti-parkinsonian interventions? , 2009, Neurology.

[50]  A. Schapira,et al.  Why have we failed to achieve neuroprotection in Parkinson's disease? , 2008, Annals of neurology.

[51]  Elizabeth A Komives,et al.  Folding landscapes of ankyrin repeat proteins: experiments meet theory. , 2008, Current opinion in structural biology.

[52]  P. Jaru-Ampornpan,et al.  Efficient interaction between two GTPases allows the chloroplast SRP pathway to bypass the requirement for an SRP RNA. , 2007, Molecular biology of the cell.

[53]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[54]  Andreas Plückthun,et al.  Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins. , 2003, Journal of molecular biology.

[55]  A. Plückthun,et al.  A novel strategy to design binding molecules harnessing the modular nature of repeat proteins , 2003, FEBS letters.

[56]  N. Hoffman,et al.  The L18 Domain of Light-harvesting Chlorophyll Proteins Binds to Chloroplast Signal Recognition Particle 43* , 2000, The Journal of Biological Chemistry.

[57]  M. Moore,et al.  A novel precursor recognition element facilitates posttranslational binding to the signal recognition particle in chloroplasts. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[58]  F. Hartl Molecular chaperones in cellular protein folding , 1996, Nature.

[59]  C. Dobson,et al.  Dynamics and Control of Peptide Self-Assembly and Aggregation. , 2019, Advances in experimental medicine and biology.

[60]  Michelle E. Hung,et al.  Designed Ankyrin Repeat Proteins ( DARPins ) : Binding Proteins for Research , Diagnostics , and Therapy , 2015 .

[61]  P. McLean,et al.  Molecular chaperones in Parkinson's disease--present and future. , 2011, Journal of Parkinson's disease.

[62]  Robert A. Grothe,et al.  Structure of the cross-beta spine of amyloid-like fibrils. , 2005, Nature.

[63]  Claudio Soto,et al.  Unfolding the role of protein misfolding in neurodegenerative diseases , 2003, Nature Reviews Neuroscience.